Mauritania

Mauritania

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
11.7 (11.52 - 11.88) 2019 Modelled IHME
11.82 (11.65 - 11.99) 2018 Modelled IHME
12.02 (11.83 - 12.21) 2017 Modelled IHME
12.33 (12.14 - 12.51) 2016 Modelled IHME
12.71 (12.51 - 12.91) 2015 Modelled IHME
13.08 (12.88 - 13.29) 2014 Modelled IHME
13.46 (13.26 - 13.66) 2013 Modelled IHME
13.85 (13.64 - 14.06) 2012 Modelled IHME
14.25 (14.03 - 14.48) 2011 Modelled IHME
14.67 (14.41 - 14.92) 2010 Modelled IHME
15.11 (14.85 - 15.36) 2009 Modelled IHME
15.59 (15.31 - 15.87) 2008 Modelled IHME
16.07 (15.76 - 16.37) 2007 Modelled IHME
16.51 (16.17 - 16.84) 2006 Modelled IHME
16.87 (16.49 - 17.25) 2005 Modelled IHME
17.18 (16.81 - 17.55) 2004 Modelled IHME
17.45 (17.09 - 17.83) 2003 Modelled IHME
17.7 (17.33 - 18.09) 2002 Modelled IHME
17.92 (17.52 - 18.33) 2001 Modelled IHME
18.11 (17.66 - 18.54) 2000 Modelled IHME
18.26 (17.86 - 18.67) 1999 Modelled IHME
18.39 (18 - 18.79) 1998 Modelled IHME
18.5 (18.10 - 18.88) 1997 Modelled IHME
18.63 (18.20 - 19.01) 1996 Modelled IHME
18.79 (18.33 - 19.19) 1995 Modelled IHME
19.01 (18.57 - 19.38) 1994 Modelled IHME
19.27 (18.84 - 19.65) 1993 Modelled IHME
19.58 (19.15 - 20) 1992 Modelled IHME
19.93 (19.46 - 20.37) 1991 Modelled IHME
20.31 (19.79 - 20.79) 1990 Modelled IHME
10.22 (7.92 - 12.80) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
3.36 (2.99 - 3.68) 2019 Modelled IHME
3.55 (3.21 - 3.85) 2018 Modelled IHME
3.78 (3.35 - 4.12) 2017 Modelled IHME
4.06 (3.67 - 4.39) 2016 Modelled IHME
4.36 (3.94 - 4.78) 2015 Modelled IHME
4.59 (4.18 - 5) 2014 Modelled IHME
4.79 (4.37 - 5.17) 2013 Modelled IHME
4.98 (4.53 - 5.38) 2012 Modelled IHME
5.21 (4.71 - 5.64) 2011 Modelled IHME
5.5 (4.93 - 6.01) 2010 Modelled IHME
5.92 (5.34 - 6.44) 2009 Modelled IHME
6.49 (5.86 - 7.09) 2008 Modelled IHME
7.16 (6.40 - 7.83) 2007 Modelled IHME
7.89 (7.03 - 8.71) 2006 Modelled IHME
8.64 (7.58 - 9.63) 2005 Modelled IHME
9.56 (8.50 - 10.57) 2004 Modelled IHME
10.69 (9.58 - 11.76) 2003 Modelled IHME
11.81 (10.64 - 12.97) 2002 Modelled IHME
12.72 (11.45 - 13.98) 2001 Modelled IHME
13.21 (11.83 - 14.55) 2000 Modelled IHME
13.38 (12.08 - 14.60) 1999 Modelled IHME
13.49 (12.25 - 14.64) 1998 Modelled IHME
13.58 (12.32 - 14.74) 1997 Modelled IHME
13.67 (12.36 - 14.87) 1996 Modelled IHME
13.8 (12.37 - 15.03) 1995 Modelled IHME
13.98 (12.60 - 15.14) 1994 Modelled IHME
14.2 (12.80 - 15.37) 1993 Modelled IHME
14.45 (13.02 - 15.63) 1992 Modelled IHME
14.73 (13.07 - 15.97) 1991 Modelled IHME
15.04 (13.09 - 16.43) 1990 Modelled IHME
4.29 (2.92 - 5.96) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
48 (39 - 58) 2019 Modelled IHME
48 (39 - 58) 2018 Modelled IHME
49 (40 - 58) 2017 Modelled IHME
49 (40 - 58) 2016 Modelled IHME
49 (40 - 58) 2015 Modelled IHME
49 (40 - 58) 2014 Modelled IHME
49 (40 - 59) 2013 Modelled IHME
50 (41 - 59) 2012 Modelled IHME
50 (41 - 59) 2011 Modelled IHME
50 (41 - 59) 2010 Modelled IHME
50 (41 - 59) 2009 Modelled IHME
50 (41 - 59) 2008 Modelled IHME
50 (41 - 59) 2007 Modelled IHME
50 (41 - 60) 2006 Modelled IHME
50 (41 - 60) 2005 Modelled IHME
50 (42 - 60) 2004 Modelled IHME
50 (42 - 60) 2003 Modelled IHME
51 (42 - 60) 2002 Modelled IHME
51 (42 - 60) 2001 Modelled IHME
51 (42 - 60) 2000 Modelled IHME
51 (43 - 60) 1999 Modelled IHME
52 (43 - 61) 1998 Modelled IHME
52 (43 - 61) 1997 Modelled IHME
52 (43 - 61) 1996 Modelled IHME
52 (43 - 61) 1995 Modelled IHME
52 (43 - 61) 1994 Modelled IHME
52 (44 - 61) 1993 Modelled IHME
53 (43 - 62) 1992 Modelled IHME
53 (43 - 62) 1991 Modelled IHME
52 (44 - 62) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
81 2018 Survey/reported WHO/UNICEF
81 2017 Survey/reported WHO/UNICEF
74 2016 Survey/reported WHO/UNICEF
73 2015 Survey/reported WHO/UNICEF
81 2014 Survey/reported WHO/UNICEF
80 2013 Survey/reported WHO/UNICEF
80 2012 Survey/reported WHO/UNICEF
75 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
64 2009 Survey/reported WHO/UNICEF
74 2008 Survey/reported WHO/UNICEF
74 2007 Survey/reported WHO/UNICEF
68 2006 Survey/reported WHO/UNICEF
42 2005 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2013
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.19 (1.76 - 2.77) 2019 Modelled IHME
2.19 (1.76 - 2.76) 2018 Modelled IHME
2.19 (1.75 - 2.76) 2017 Modelled IHME
2.18 (1.76 - 2.75) 2016 Modelled IHME
2.18 (1.75 - 2.77) 2015 Modelled IHME
2.19 (1.77 - 2.77) 2014 Modelled IHME
2.21 (1.78 - 2.79) 2013 Modelled IHME
2.24 (1.80 - 2.81) 2012 Modelled IHME
2.27 (1.83 - 2.83) 2011 Modelled IHME
2.29 (1.85 - 2.85) 2010 Modelled IHME
2.32 (1.87 - 2.88) 2009 Modelled IHME
2.34 (1.89 - 2.92) 2008 Modelled IHME
2.36 (1.91 - 2.96) 2007 Modelled IHME
2.39 (1.92 - 2.99) 2006 Modelled IHME
2.41 (1.94 - 3.03) 2005 Modelled IHME
2.43 (1.97 - 3.07) 2004 Modelled IHME
2.46 (1.99 - 3.09) 2003 Modelled IHME
2.48 (2.01 - 3.13) 2002 Modelled IHME
2.51 (2.03 - 3.14) 2001 Modelled IHME
2.53 (2.05 - 3.17) 2000 Modelled IHME
2.56 (2.07 - 3.20) 1999 Modelled IHME
2.58 (2.10 - 3.23) 1998 Modelled IHME
2.61 (2.12 - 3.26) 1997 Modelled IHME
2.63 (2.13 - 3.30) 1996 Modelled IHME
2.66 (2.15 - 3.34) 1995 Modelled IHME
2.69 (2.17 - 3.37) 1994 Modelled IHME
2.72 (2.20 - 3.40) 1993 Modelled IHME
2.75 (2.22 - 3.44) 1992 Modelled IHME
2.78 (2.23 - 3.49) 1991 Modelled IHME
2.81 (2.24 - 3.54) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.9 (1.10 - 10.70) 2014 Modelled Gower et al, 2014

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (13 - 26) 2019 Modelled IHME
19 (13 - 26) 2018 Modelled IHME
19 (13 - 26) 2017 Modelled IHME
19 (13 - 26) 2016 Modelled IHME
19 (13 - 26) 2015 Modelled IHME
19 (13 - 26) 2014 Modelled IHME
19 (13 - 26) 2013 Modelled IHME
19 (13 - 26) 2012 Modelled IHME
19 (13 - 26) 2011 Modelled IHME
19 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 26) 2008 Modelled IHME
19 (13 - 26) 2007 Modelled IHME
19 (13 - 26) 2006 Modelled IHME
19 (13 - 26) 2005 Modelled IHME
19 (13 - 26) 2004 Modelled IHME
19 (13 - 26) 2003 Modelled IHME
19 (12 - 25) 2002 Modelled IHME
18 (12 - 25) 2001 Modelled IHME
18 (12 - 25) 2000 Modelled IHME
18 (12 - 25) 1999 Modelled IHME
18 (12 - 25) 1998 Modelled IHME
18 (12 - 25) 1997 Modelled IHME
18 (12 - 25) 1996 Modelled IHME
18 (12 - 25) 1995 Modelled IHME
18 (12 - 25) 1994 Modelled IHME
18 (12 - 25) 1993 Modelled IHME
18 (12 - 25) 1992 Modelled IHME
18 (12 - 25) 1991 Modelled IHME
18 (12 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2013
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
11.7 (%)
2019
(11.52 - 11.88(%))
IHME
HCV (RNA/cAg+)
2.19 (%)
2019
(1.76 - 2.77(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
335
2019
(220 - 475)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
54
2019
(36 - 79)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
3.36 (%)
2019, latest modelled
(2.99 - 3.68(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines